These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38846537)

  • 1. Long non-coding RNA
    Koka M; Li H; Akther R; Perlman S; Wong D; Fogel BL; Lynch DR; Chandran V
    Brain Commun; 2024; 6(3):fcae170. PubMed ID: 38846537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Quantification of Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich's Ataxia Blood.
    Wang Q; Laboureur L; Weng L; Eskenazi NM; Hauser LA; Mesaros C; Lynch DR; Blair IA
    Front Neurosci; 2022; 16():874768. PubMed ID: 35573317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
    Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB
    Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.
    Libri V; Yandim C; Athanasopoulos S; Loyse N; Natisvili T; Law PP; Chan PK; Mohammad T; Mauri M; Tam KT; Leiper J; Piper S; Ramesh A; Parkinson MH; Huson L; Giunti P; Festenstein R
    Lancet; 2014 Aug; 384(9942):504-13. PubMed ID: 24794816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NfL and pNfH are increased in Friedreich's ataxia.
    Hayer SN; Liepelt I; Barro C; Wilke C; Kuhle J; Martus P; Schöls L;
    J Neurol; 2020 May; 267(5):1420-1430. PubMed ID: 32002649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.
    Bit-Avragim N; Perrot A; Schöls L; Hardt C; Kreuz FR; Zühlke C; Bubel S; Laccone F; Vogel HP; Dietz R; Osterziel KJ
    J Mol Med (Berl); 2001; 78(11):626-32. PubMed ID: 11269509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers.
    Napierala JS; Li Y; Lu Y; Lin K; Hauser LA; Lynch DR; Napierala M
    Dis Model Mech; 2017 Nov; 10(11):1353-1369. PubMed ID: 29125828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells.
    Kemp K; Dey R; Cook A; Scolding N; Wilkins A
    Cerebellum; 2017 Aug; 16(4):840-851. PubMed ID: 28456899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friedreich's ataxia: clinical aspects and pathogenesis.
    Pandolfo M
    Semin Neurol; 1999; 19(3):311-21. PubMed ID: 12194387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can telomere shortening in human peripheral blood leukocytes serve as a disease biomarker of Friedreich's ataxia?
    Castaldo I; Vergara P; Pinelli M; Filla A; De Michele G; Cocozza S; Monticelli A
    Antioxid Redox Signal; 2013 Apr; 18(11):1303-6. PubMed ID: 23146029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future Prospects of Gene Therapy for Friedreich's Ataxia.
    Ocana-Santero G; Díaz-Nido J; Herranz-Martín S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing cardiac phenotype in Friedreich's ataxia: The CARFA study.
    Legrand L; Weinsaft JW; Pousset F; Ewenczyk C; Charles P; Hatem S; Heinzmann A; Biet M; Durr A; Redheuil A
    Arch Cardiovasc Dis; 2022 Jan; 115(1):17-28. PubMed ID: 34920960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients.
    Misiorek JO; Schreiber AM; Urbanek-Trzeciak MO; Jazurek-Ciesiołka M; Hauser LA; Lynch DR; Napierala JS; Napierala M
    Mol Neurobiol; 2020 Jun; 57(6):2639-2653. PubMed ID: 32291635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Chromatography-Mass Spectrometry Analysis of Frataxin Proteoforms in Whole Blood as Biomarkers of the Genetic Disease Friedreich's Ataxia.
    Rojsajjakul T; Wu L; Grady CB; Hwang WT; Mesaros C; Lynch DR; Blair IA
    Anal Chem; 2023 Feb; 95(8):4251-4260. PubMed ID: 36800320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia.
    Plasterer HL; Deutsch EC; Belmonte M; Egan E; Lynch DR; Rusche JR
    PLoS One; 2013; 8(5):e63958. PubMed ID: 23691127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Genetic Counseling for Friedreich's Ataxia: A time for consideration of TP-PCR in an Indian Setup.
    Muthuswamy S; Agarwal S; Dalal A
    Hippokratia; 2013 Jan; 17(1):38-41. PubMed ID: 23935342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified mouse model of Friedreich's ataxia with conditional
    Perfitt TL; Huichalaf C; Gooch R; Kuperman A; Ahn Y; Chen X; Ullas S; Hirenallur-Shanthappa D; Zhan Y; Otis D; Whiteley LO; Bulawa C; Martelli A
    Am J Physiol Heart Circ Physiol; 2024 Feb; 326(2):H357-H369. PubMed ID: 38038720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia.
    Gottesfeld JM; Rusche JR; Pandolfo M
    J Neurochem; 2013 Aug; 126 Suppl 1(0 1):147-54. PubMed ID: 23859350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friedreich's ataxia--a case of aberrant transcription termination?
    Butler JS; Napierala M
    Transcription; 2015; 6(2):33-6. PubMed ID: 25831023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.